Oura to acquire AI-native primary care startup Counsel Health for $625M
Oura has agreed to purchase Counsel Health, an AI-native primary care startup, for $625M. The deal comes shortly after Oura indefinitely postponed its initial public offering of up to $2.2 billion. The company attributed the public offering delay to "uncertainty in the IPO market."
Key Takeaways
- Oura has agreed to buy Counsel Health, an AI-native primary care startup, for $625M.
The purchase highlights how established technology firms are directly acquiring artificial intelligence capabilities in the health sector rather than relying solely on internal development.
- The firm pointed to "uncertainty in the IPO market" as the primary factor behind halting its plans to enter the public market.
Oura is acquiring Counsel Health, an AI-native primary care startup, for $625M.
- Oura cited "uncertainty in the IPO market" as the reason for delaying its public debut.
- This strategic expansion comes just weeks after Oura indefinitely delayed its initial public offering, which could have been worth up to $2.2 billion.
- The deal arrives shortly after Oura indefinitely postponed its up to $2.2 billion IPO.
Stats & Key Facts
- #The deal comes shortly after Oura indefinitely postponed its initial public offering of up to $2.2 billion.
- #This strategic expansion comes just weeks after Oura indefinitely delayed its initial public offering, which could have been worth up to $2.2 billion.
- #Oura is acquiring Counsel Health, an AI-native primary care startup, for $625M.
- #The deal arrives shortly after Oura indefinitely postponed its up to $2.2 billion IPO.
Oura has agreed to buy Counsel Health, an AI-native primary care startup, for $625M. The purchase highlights how established technology firms are directly acquiring artificial intelligence capabilities in the health sector rather than relying solely on internal development. This strategic expansion comes just weeks after Oura indefinitely delayed its initial public offering, which could have been worth up to $2.2 billion.
The firm pointed to "uncertainty in the IPO market" as the primary factor behind halting its plans to enter the public market. Oura is acquiring Counsel Health, an AI-native primary care startup, for $625M. The deal arrives shortly after Oura indefinitely postponed its up to $2.2 billion IPO.
For more details please read the original article at TechCrunch AI.
Continue Learning
Comments
Comments appear only after moderation. Your email identifies your submission to the moderator and is never displayed here.
No approved comments yet.